JP2015518474A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518474A5
JP2015518474A5 JP2015503890A JP2015503890A JP2015518474A5 JP 2015518474 A5 JP2015518474 A5 JP 2015518474A5 JP 2015503890 A JP2015503890 A JP 2015503890A JP 2015503890 A JP2015503890 A JP 2015503890A JP 2015518474 A5 JP2015518474 A5 JP 2015518474A5
Authority
JP
Japan
Prior art keywords
seq
sequence number
amyloid
peptide
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015503890A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015518474A (ja
Filing date
Publication date
Priority claimed from DE201210102999 external-priority patent/DE102012102999A1/de
Priority claimed from DE102012108599.4A external-priority patent/DE102012108599B4/de
Priority claimed from DE102012108598.6A external-priority patent/DE102012108598A1/de
Application filed filed Critical
Priority claimed from PCT/EP2013/057160 external-priority patent/WO2013150126A2/de
Publication of JP2015518474A publication Critical patent/JP2015518474A/ja
Publication of JP2015518474A5 publication Critical patent/JP2015518474A5/ja
Pending legal-status Critical Current

Links

JP2015503890A 2012-04-05 2013-04-05 血液、血液生産物及び器官を処置する方法 Pending JP2015518474A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE102012102999.7 2012-04-05
DE201210102999 DE102012102999A1 (de) 2012-04-05 2012-04-05 Verfahren zur Behandlung von Blut, Blutprodukten und Organen
DE102012108599.4A DE102012108599B4 (de) 2012-09-14 2012-09-14 A-Beta-Oligomer-bindende Peptide und deren Verwendung
DE102012108598.6A DE102012108598A1 (de) 2012-09-14 2012-09-14 Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung
DE102012108599.4 2012-09-14
DE102012108598.6 2012-09-14
PCT/EP2013/057160 WO2013150126A2 (de) 2012-04-05 2013-04-05 Verfahren zur behandlung von blut, blutprodukten und organen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017134929A Division JP6619394B2 (ja) 2012-04-05 2017-07-10 血液、血液生産物及び器官を処置する方法

Publications (2)

Publication Number Publication Date
JP2015518474A JP2015518474A (ja) 2015-07-02
JP2015518474A5 true JP2015518474A5 (enExample) 2016-09-15

Family

ID=48184148

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015503890A Pending JP2015518474A (ja) 2012-04-05 2013-04-05 血液、血液生産物及び器官を処置する方法
JP2017134929A Active JP6619394B2 (ja) 2012-04-05 2017-07-10 血液、血液生産物及び器官を処置する方法
JP2019206147A Active JP6997160B2 (ja) 2012-04-05 2019-11-14 血液、血液生産物及び器官を処置する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017134929A Active JP6619394B2 (ja) 2012-04-05 2017-07-10 血液、血液生産物及び器官を処置する方法
JP2019206147A Active JP6997160B2 (ja) 2012-04-05 2019-11-14 血液、血液生産物及び器官を処置する方法

Country Status (8)

Country Link
US (3) US9591845B2 (enExample)
EP (2) EP2834643B1 (enExample)
JP (3) JP2015518474A (enExample)
CN (2) CN108926749A (enExample)
DK (2) DK2834643T3 (enExample)
ES (2) ES2938886T3 (enExample)
PL (1) PL3260865T3 (enExample)
WO (1) WO2013150126A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012108598A1 (de) * 2012-09-14 2014-04-10 Forschungszentrum Jülich GmbH Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung
CN104380111B (zh) 2012-04-05 2017-08-29 于利希研究中心有限公司 包含多价结合淀粉样β蛋白的D‑肽的聚合物及其应用
JP2015518474A (ja) * 2012-04-05 2015-07-02 フォルシュングスツェントルム ユーリッヒ ゲゼルシャフト ミット ベシュレンクテル ハフツングＦｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ Ｊｕｅｌｉｃｈ ＧｍｂＨ 血液、血液生産物及び器官を処置する方法
DE102013016002A1 (de) 2013-09-26 2015-03-26 Forschungszentrum Jülich GmbH Zyklische, Amyloid-Beta-bindende Peptide und deren Verwendung
US10995118B2 (en) * 2013-09-26 2021-05-04 Forschungszentrum Juelich Gmbh Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of alzheimer's disease
DE102015003676A1 (de) * 2015-03-20 2016-09-22 Forschungszentrum Jülich GmbH Fachbereich Patente Spezifisch A-Beta Spezies bindende Peptide für die Therapie und/oder die Diagnose der Alzheimerschen Demenz
WO2018009514A1 (en) * 2016-07-06 2018-01-11 George Stantchev Apparatus and method for plant extraction
EP3735281B1 (en) 2018-01-05 2024-11-27 Path Ex, Inc. Device for the capture and removal of disease material from fluids
GB201904810D0 (en) * 2019-04-05 2019-05-22 Cynapsedx Ltd The treatment of protein aggregation diseases
JP7774972B2 (ja) * 2021-04-01 2025-11-25 禎弘 飯田 ペプチド結合切断活性を有する人工ペプチドおよびその利用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2214247C (en) 1995-03-14 2004-02-10 Praecis Pharmaceuticals Incorporated Modulators of amyloid aggregation
US5968820A (en) 1997-02-26 1999-10-19 The Cleveland Clinic Foundation Method for magnetically separating cells into fractionated flow streams
WO2000063268A1 (en) 1999-04-16 2000-10-26 Wm. Marsh Rice University Poly(propylene fumarate) cross linked with poly(ethylene glycol)
AU2002225772A1 (en) 2000-11-27 2002-06-03 Praecis Pharmaceuticals Inc. Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
DE10117281A1 (de) 2001-04-06 2002-10-24 Inst Molekulare Biotechnologie Peptid zur Diagnose und Therapie der Alzheimer-Demenz
US20040143093A1 (en) * 2002-07-11 2004-07-22 Ralph Zahn Method for inducing a conformational transition in proteins, such as pathogenic/infectious proteins, and their use
AU2003303198A1 (en) 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
US20050158306A1 (en) 2004-01-16 2005-07-21 Halikas James A. Treatment for neuro-degenerative disease by a blood cleansing system using monoclonal antibodies
AT500483B1 (de) 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
DE102005009909A1 (de) 2005-03-01 2006-09-07 Heinrich-Heine-Universität Düsseldorf Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine
DE102005031429A1 (de) 2005-07-04 2007-01-11 Heinrich-Heine-Universität Düsseldorf Verfahren zur selektiven Bestimmung pathologischer Proteinablagerungen
DE102005063175A1 (de) 2005-07-29 2007-02-01 Hans-Werner Prof. Dr. Heinrich Vorrichtung und Verfahren zum Isolieren von Zellen, Biopartikeln und/oder Molekülen aus Flüssigkeiten mit dem Ziel einer Anwendung für Tiere, in der Biotechnologie (einschließlich der biologischen Forschung) und der medizinischen Diagnostik
US20070092508A1 (en) * 2005-10-21 2007-04-26 Recombiant Technologies, Llc Detoxification depot for Alzheimer's disease
DE102006015140A1 (de) 2006-03-31 2007-10-11 Philipps-Universität Marburg Heterozyklische Verbindungen mit Wirkung gegen neurodegenerative Erkrankungen
US20100166695A1 (en) 2007-03-23 2010-07-01 The Governors Of The University Of Alberta Multivalent Heterobifunctional Polymers And Methods Of Their Use
CN101538329B (zh) * 2008-03-20 2013-01-30 中国医学科学院基础医学研究所 新的抗β-淀粉样多肽抗体的可变区序列及其编码序列
WO2010062570A2 (en) 2008-10-27 2010-06-03 Recombinant Technologies Llc COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE
DE102008037564A1 (de) * 2008-11-19 2010-05-20 Forschungszentrum Jülich GmbH Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden
DE102009037015A1 (de) 2009-08-07 2011-02-17 Michael Hajek Vorrichtung und Verfahren zur Eliminierung von bioschädlichen Stoffen aus Körperflüssigkeiten
DE102010019336A1 (de) 2010-05-05 2011-11-10 Forschungszentrum Jülich GmbH Mittel zur Behandlung der Alzheimerschen Demenz
DE102010017130B4 (de) 2010-05-28 2018-11-29 Forschungszentrum Jülich GmbH Hybrid-Verbindung, deren Verwendung und Verfahren zu deren Herstellung
CN102233128B (zh) * 2010-11-26 2013-04-17 王延江 一种p75NTR-ECD在防治阿尔茨海默病药物中应用
JP2015518474A (ja) 2012-04-05 2015-07-02 フォルシュングスツェントルム ユーリッヒ ゲゼルシャフト ミット ベシュレンクテル ハフツングＦｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ Ｊｕｅｌｉｃｈ ＧｍｂＨ 血液、血液生産物及び器官を処置する方法
CN104380111B (zh) * 2012-04-05 2017-08-29 于利希研究中心有限公司 包含多价结合淀粉样β蛋白的D‑肽的聚合物及其应用

Similar Documents

Publication Publication Date Title
JP6997160B2 (ja) 血液、血液生産物及び器官を処置する方法
Madl et al. Presentation of BMP-2 mimicking peptides in 3D hydrogels directs cell fate commitment in osteoblasts and mesenchymal stem cells
Woodruff et al. The role of the complement system and the activation fragment C5a in the central nervous system
Li et al. Functionalized collagen scaffold neutralizing the myelin-inhibitory molecules promoted neurites outgrowth in vitro and facilitated spinal cord regeneration in vivo
RU2624036C2 (ru) Структуры слитого белка шелка пауков для связывания с органической мишенью
Camci-Unal et al. Surface-modified hyaluronic acid hydrogels to capture endothelial progenitor cells
JP2021511041A5 (enExample)
Hedhammar et al. Sterilized recombinant spider silk fibers of low pyrogenicity
Nakaji-Hirabayashi et al. Improvement of neural stem cell survival in collagen hydrogels by incorporating laminin-derived cell adhesive polypeptides
EP2058335B1 (en) Biocompatible three dimensional matrix for the immobilization of biological substances
RU2016151265A (ru) Антитела, направленные на cd127
US10662230B2 (en) Cyclic RGD cell-binding motif and uses thereof
US20170044222A1 (en) Anti-Microbial Coatings and Devices
JP2012509295A5 (enExample)
JP2014517690A5 (enExample)
CN105745219B (zh) 结合β淀粉状蛋白的肽及其用于治疗和诊断阿尔茨海默痴呆症的用途
Wang et al. Terminal group modification of carbon nanotubes determines covalently bound osteogenic peptide performance
CN105745220B (zh) 结合β淀粉状蛋白的环状肽及其用途
JP2012523221A5 (enExample)
JP7168454B2 (ja) 固体表面のスパイダーシルクコーティング
Zurick et al. Adhesion of MC3T3‐E1 cells bound to dentin phosphoprotein specifically bound to collagen type I
JP6714610B2 (ja) アルツハイマー型認知症の治療および／または診断のための特定のａ−ベータ種に結合するペプチド
JP2011518113A5 (enExample)
JP2015515264A (ja) 疾患の処置のためのキメラタンパク質
JP2010520761A5 (enExample)